Multipolar Radiofrequency Treatment for Meibomian Gland Dysfunction: A Prospective Randomized Controlled Trial

This single‐center, prospective, randomized controlled study evaluated the efficacy and safety of a novel multipolar radiofrequency (RF) device in treating meibomian gland dysfunction (MGD). Patients diagnosed with MGD were randomly assigned to the RF treatment group ( n = 21) or warm compress group ( n = 20), and participants received four weekly 20‐min sessions of either RF or warm compress treatment. The Ocular Surface Disease Index (OSDI) and Visual Analogue Scale (VAS) scores were used to assess symptoms. The primary efficacy indices included meibomian gland expressibility, meibum quality (MQ) score, fluorescein tear break‐up time (FBUT), and total corneal fluorescein staining (CFS) score, while the secondary efficacy indices included meibomian gland dropout, non‐invasive tear break‐up time (NIBUT), Schirmer I test (SIT), tear meniscus height (TMH), and lipid layer thickness (LLT). Both interventions improved symptoms; at the final follow‐up, the RF group had lower symptom scores than the warm compress group ( p ≤ 0.05). Meibomian gland expressibility scores were also lower in the RF group ( p ≤ 0.05). NIBUT and LLT were significantly higher in the RF group ( p ≤ 0.05). No serious adverse events were observed. In conclusion, multipolar RF showed short‐term efficacy and safety in MGD patients.

Authors

Institutions

Publication Details

Journal
MedComm
Published
2026-11-20
DOI
https://doi.org/10.1002/mco2.71157
Primary Topic
Ocular Surface and Contact Lens
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Multipolar Radiofrequency Treatment for Meibomian Gland Dysfunction: A Prospective Randomized Controlled Trial

Binge Wu, Ya Wen, Haonan Wen, Lei Tian et al.
MedComm
Ocular Surface and Contact Lens
article

Multipolar Radiofrequency Treatment for Meibomian Gland Dysfunction: A Prospective Randomized Controlled Trial

Binge Wu, Ya Wen, Haonan Wen, Lei Tian, Ying Jie, Qianru Wu, Xiaoniao Chen, Jing Liu, Chang Dai
article en

Abstract

This single‐center, prospective, randomized controlled study evaluated the efficacy and safety of a novel multipolar radiofrequency (RF) device in treating meibomian gland dysfunction (MGD). Patients diagnosed with MGD were randomly assigned to the RF treatment group ( n = 21) or warm compress group ( n = 20), and participants received four weekly 20‐min sessions of either RF or warm compress treatment. The Ocular Surface Disease Index (OSDI) and Visual Analogue Scale (VAS) scores were used to assess symptoms. The primary efficacy indices included meibomian gland expressibility, meibum quality (MQ) score, fluorescein tear break‐up time (FBUT), and total corneal fluorescein staining (CFS) score, while the secondary efficacy indices included meibomian gland dropout, non‐invasive tear break‐up time (NIBUT), Schirmer I test (SIT), tear meniscus height (TMH), and lipid layer thickness (LLT). Both interventions improved symptoms; at the final follow‐up, the RF group had lower symptom scores than the warm compress group ( p ≤ 0.05). Meibomian gland expressibility scores were also lower in the RF group ( p ≤ 0.05). NIBUT and LLT were significantly higher in the RF group ( p ≤ 0.05). No serious adverse events were observed. In conclusion, multipolar RF showed short‐term efficacy and safety in MGD patients.

MedCommVol. 7(12)
Beijing Tongren Hospital (CN), Chinese PLA General Hospital (CN), Yibin University (CN), Second People’s Hospital of Yibin (CN), Baotou Medical College (CN)
Ocular Surface and Contact Lens
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon